Comparing DS Healthcare Group (DSKX) and Procter & Gamble (PG)

DS Healthcare Group (OTCMKTS: DSKX) and Procter & Gamble (NYSE:PG) are both consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, dividends and earnings.

Profitability

This table compares DS Healthcare Group and Procter & Gamble’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
DS Healthcare Group -62.31% -1,304.25% -117.85%
Procter & Gamble 15.34% 20.66% 8.99%

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for DS Healthcare Group and Procter & Gamble, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DS Healthcare Group 0 0 0 0 N/A
Procter & Gamble 1 9 6 0 2.31

Procter & Gamble has a consensus price target of $86.13, suggesting a potential downside of 0.85%. Given Procter & Gamble’s higher possible upside, analysts plainly believe Procter & Gamble is more favorable than DS Healthcare Group.

Dividends

Procter & Gamble pays an annual dividend of $2.76 per share and has a dividend yield of 3.2%. DS Healthcare Group does not pay a dividend. Procter & Gamble pays out 73.6% of its earnings in the form of a dividend. DS Healthcare Group has increased its dividend for 61 consecutive years.

Valuation and Earnings

This table compares DS Healthcare Group and Procter & Gamble’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
DS Healthcare Group $12.95 million 0.01 -$6.93 million ($0.28) -0.02
Procter & Gamble $65.06 billion 3.39 $15.33 billion $3.75 23.16

Procter & Gamble has higher revenue and earnings than DS Healthcare Group. DS Healthcare Group is trading at a lower price-to-earnings ratio than Procter & Gamble, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

0.0% of DS Healthcare Group shares are held by institutional investors. Comparatively, 59.7% of Procter & Gamble shares are held by institutional investors. 19.4% of DS Healthcare Group shares are held by insiders. Comparatively, 0.4% of Procter & Gamble shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Risk & Volatility

DS Healthcare Group has a beta of -0.16, indicating that its stock price is 116% less volatile than the S&P 500. Comparatively, Procter & Gamble has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500.

Summary

Procter & Gamble beats DS Healthcare Group on 12 of the 15 factors compared between the two stocks.

DS Healthcare Group Company Profile

DS Healthcare Group, Inc., doing business as DS Laboratories, is a personal care, product development and marketing company. The Company develops and markets branded personal care products that address thinning hair conditions, skin care and other personal care needs. It develops technologies and products for hair care and personal care needs. Its technologies include Liposome Technology, which acts as a carrier agent, and is designed to enhance the act ion of the active ingredients in its products, and Nanosome Technology, which acts as a delivery vehicle, and is designed to infuse active compounds into targeted cells. The Company products are primarily sold under its DS Laboratories brand. It also sells certain products under its Polaris Labs and Sigma Skin brands. It markets and sells these products through salons, spas, department stores, specialty retailers and distributors. The Company offers products under three product categories: Hair Care, Skin Care and Personal Care.

Procter & Gamble Company Profile

The Procter & Gamble Company is focused on providing branded consumer packaged goods to the consumers across the world. The Company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care, and Baby, Feminine & Family Care. The Company sells its products in approximately 180 countries and territories primarily through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, distributors, baby stores, specialty beauty stores, e-commerce, high-frequency stores and pharmacies. It offers products under the brands, such as Olay, Old Spice, Safeguard, Head & Shoulders, Pantene, Rejoice, Mach3, Prestobarba, Venus, Cascade, Dawn, Febreze, Mr. Clean, Bounty and Charmin.

Receive News & Ratings for DS Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DS Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply